lurasidone hydrochloride
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
72205-208 -
Package NDC
72205-208-05 -
Package NDC
72205-208-30 -
Package NDC
72205-208-90 -
Application number
ANDA208037 -
SPL ID
8f42d8c8-cccf-49e3-9bad-e9a45d8d7896 -
SPL set ID
4f969224-a9f0-4089-84d6-a15664ea7bfe -
UNII
O0P4I5851I -
RxCUI
1040031 -
RxCUI
1040041 -
RxCUI
1235247 -
RxCUI
1297278 -
RxCUI
1431235
What the source publishes
- Labeler
- Novadoz Pharmaceuticals LLC
- Active ingredients
- lurasidone hydrochloride
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "lurasidone hydrochloride",
"splId": "8f42d8c8-cccf-49e3-9bad-e9a45d8d7896",
"labels": [
{
"setId": "4f969224-a9f0-4089-84d6-a15664ea7bfe",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f969224-a9f0-4089-84d6-a15664ea7bfe",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=4f969224-a9f0-4089-84d6-a15664ea7bfe"
}
],
"routes": [
"ORAL"
],
"labeler": "Novadoz Pharmaceuticals LLC",
"finished": true,
"packaging": [
{
"sample": false,
"description": "500 TABLET, FILM COATED in 1 BOTTLE (72205-208-05)",
"package_ndc": "72205-208-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20230220"
},
{
"sample": false,
"description": "30 TABLET, FILM COATED in 1 BOTTLE (72205-208-30)",
"package_ndc": "72205-208-30",
"identifierStatus": "well-formed",
"marketing_start_date": "20230220"
},
{
"sample": false,
"description": "90 TABLET, FILM COATED in 1 BOTTLE (72205-208-90)",
"package_ndc": "72205-208-90",
"identifierStatus": "well-formed",
"marketing_start_date": "20230220"
}
],
"productId": "72205-208_8f42d8c8-cccf-49e3-9bad-e9a45d8d7896",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "72205-208",
"deaSchedule": null,
"genericName": "lurasidone hydrochloride",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "LURASIDONE HYDROCHLORIDE",
"strength": "40 mg/1"
}
],
"applicationNumber": "ANDA208037",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20230209",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"upc": [
"0372205208308",
"0372205209053",
"0372205209909",
"0372205210905",
"0372205209305",
"0372205210301",
"0372205211902",
"0372205207059",
"0372205211308",
"0372205210059",
"0372205211056",
"0372205208056",
"0372205207301",
"0372205208902",
"0372205207905"
],
"unii": [
"O0P4I5851I"
],
"rxcui": [
"1040031",
"1040041",
"1235247",
"1297278",
"1431235"
],
"spl_set_id": [
"4f969224-a9f0-4089-84d6-a15664ea7bfe"
],
"manufacturer_name": [
"Novadoz Pharmaceuticals LLC"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:72205-208_8f42d8c8-cccf-49e3-9bad-e9a45d8d7896"